Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Prolactin
A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.
Prolactin-Releasing Hormone
A hypothalamic hormone that is synthesized as a precursor protein which is cleaved into two peptides. In addition to stimulating PROLACTIN release the peptides bind to specific G-PROTEIN-COUPLED RECEPTORS found at locations within the BRAIN.
Year introduced: 2010, 1975-2006
Receptors, Prolactin
Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor.
Year introduced: 1987
Prolactin Release-Inhibiting Factors
A number of peptides with inhibitory activities on PROLACTIN release have been isolated from the HYPOTHALAMUS, the peripheral nervous system, and the gut. These include SOMATOSTATIN, and peptides derived from POMC and precursor for VASOPRESSIN-ASSOCIATED NEUROPHYSIN. Biogenic amine DOPAMINE is also a potent PIF.
Year introduced: 2007 (1975)
Prolactinoma
A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.
Year introduced: 1989
Hyperprolactinemia
Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
Year introduced: 1986
Lactotrophs
Anterior pituitary cells that produce PROLACTIN.
Year introduced: 2007
PRLH protein, human [Supplementary Concept]
RefSeq NM_015893
Date introduced: August 13, 2009
prolactin, polymeric [Supplementary Concept]
causes hyperprolactinemia; has substantially less biological activity than prolactin
Date introduced: September 14, 1989
prolactin, delta(1-9)-Arg(129)- [Supplementary Concept]
Date introduced: December 25, 2005
prolactin, glycosylated [Supplementary Concept]
isolated from pituitary gland; carbohydrate unit linked to asparagine at position 31 in the sequence Asn-Leu-Ser; MW 25,000
Date introduced: January 23, 1985
prolactin-inhibitory factor receptor [Supplementary Concept]
Date introduced: May 24, 1984
Pip protein, rat [Supplementary Concept]
RefSeq NM_022708
Date introduced: April 26, 2012
Dtprp protein, mouse [Supplementary Concept]
RefSeq NM_010088
Date introduced: September 29, 2004
PIP protein, human [Supplementary Concept]
RefSeq NM_002652
Prl3c1 protein, rat [Supplementary Concept]
member of the PRL/growth hormone family; expressed in maternal decidua; RefSeq NM_031316
Date introduced: August 6, 2004
prolactin, Asp(179)- [Supplementary Concept]
Date introduced: March 21, 2001
Prlpi protein, mouse [Supplementary Concept]
member of the PRL/growth hormone family; expressed in maternal decidua; RefSeq NM_013766
Date introduced: November 17, 1999
alanyl-seryl-(histidyl)6-isoleucyl-glutamyl-glycyl-arginyl-prolactin [Supplementary Concept]
a biologically active prolactin with attached tag at the N-terminal
Date introduced: December 27, 1996
Prl8a2 protein, rat [Supplementary Concept]
RefSeq NM_022846
Date introduced: March 6, 1993